{"id":287,"date":"2014-06-26T01:20:34","date_gmt":"2014-06-25T16:20:34","guid":{"rendered":"http:\/\/test-ehime-u.labart.jp\/?p=287"},"modified":"2015-09-01T11:28:41","modified_gmt":"2015-09-01T02:28:41","slug":"studygroup2013","status":"publish","type":"post","link":"https:\/\/www.m.ehime-u.ac.jp\/school\/int.med1\/?p=287","title":{"rendered":"\u7814\u7a76\u306b\u3064\u3044\u3066 \u30102013\u5e74\u3011"},"content":{"rendered":"<h3>\u82f1\u6587\u539f\u8457\u8ad6\u6587\u3000Original papers<\/h3>\n<p>\u767a\u520a\u6e08\u306e\u3082\u306e\u306fabstract\u307e\u305f\u306f\u672c\u6587\u306b\u30ea\u30f3\u30af\u3057\u3066\u3042\u308a\u307e\u3059\u3002<br \/>\n  Published papers are linked to PubMed<br \/>\n  <span id=\"more-1008\"> <\/span><\/p>\n<p><!--more--><\/p>\n<div>\n<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=The+First+Identification+and+Retrospective+Study+of+Severe+Fever+with+Thrombocytopenia+Syndrome+in+Japan.\">Takahashi,T., Maeda,K., Suzuki,T., Ishido,A., Shigeoka,T., Tominaga,T., Kamei,T., Honda,M., Ninomiya,D., Sakai,T., Senba,T., Kaneyuki,S., Sakaguchi,S., Satoh,A., Hosokawa,T., Kawabe,Y., Kurihara,S., Izumikawa,K., Kohno,S., Azuma,T., Suemori,K., Yasukawa,M., Mizutani,T., Omatsu,T., Katayama,Y., Miyahara,M., Ijuin,M., Doi,K., Okuda,M., Umeki,K., Saito,T., Fukushima,K., Nakajima,K., Yoshikawa,T., Tani,H., Fukushi,S., Fukuma,A., Ogata,M., Shimojima,M., Nakajima,N., Nagata,N., Katano,H., Fukumoto,H., Sato,Y., Hasegawa,H., Yamagishi,T., Oishi,K., Kurane,I., Morikawa,S., Saijo,M.<\/a><\/p>\n<p>The First Identification and Retrospective Study of Severe Fever with Thrombocytopenia Syndrome in Japan.<\/p>\n<p>J Infect Dis. 2014 Mar;209(6):816-27.<\/p>\n<hr \/>\n<p><a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Fujiishi+K%2C+Kitazawa+R%2C+Nagai+Y%2C+Watanabe+T%2C+Bando+K%2C+Kobayashi+S%2C+Yakushijin+Y%2C+Haraguchi+R%2C+Kitazawa+S.\">Fujiishi,K., Kitazawa,R., Nagai,Y., Watanabe,T., Bando,K., Kobayashi,S., Yakushijin,Y., Haraguchi,R., Kitazawa,S.<\/a><\/p>\n<p>Acquisition of MYD88 L265P mutation during treatment of diffuse large B cell lymphoma of the parotid gland.<\/p>\n<p>Virchows Arch. 2014 Jan;464(1):121-4.<\/p>\n<hr \/>\n<p><a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Genetically+engineered+fixed+K562+cells%3A+potent+%22off-the-shelf%22+antigen-presenting+cells+for+generating+virus-specific+T+cells.\">Tanimoto,K., Muranski,P., Miner,S., Fujiwara,H., Kajigaya,S., Keyvanfar,K., Hensel,N., Barrett,AJ., Melenhorst,JJ.<\/a><\/p>\n<p>Genetically engineered fixed K562 cells: potent &ldquo;off-the-shelf&rdquo; antigen-presenting cells for generating virus-specific T cells.<\/p>\n<p>Cytotherapy. 2014 Jan;16(1):135-46.<\/p>\n<hr \/>\n<p><a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Accelerated+destruction+of+erythrocytes+in+Tie2+promoter-driven+STAT3+conditional+knockout+mice.\">Ohkubo,N., Suzuki,Y., Aoto,M., Yamanouchi,J., Hirakawa,S., Yasukawa,M., Mitsuda,N.<\/a><\/p>\n<p>Accelerated destruction of erythrocytes in Tie2 promoter-driven STAT3 conditional knockout mice.<\/p>\n<p>Life Sci. 2013 Sep 17;93(9-11):380-7. doi: 10.1016\/j.lfs.2013.07.025. Epub 2013 Aug 2.<\/p>\n<hr \/>\n<p><a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Severe+immune+thrombocytopenia+secondary+to+Waldenstr%C3%B6m%27s+macroglobulinemia+with+anti-GPIb%2FIX+monoclonal+IgM+antibody.\">Yamanouchi,J., Hato,T., Niiya,T., Azuma,T., Yasukawa,M.<\/a><\/p>\n<p>Severe immune thrombocytopenia secondary to Waldenstr\u00f6m&rsquo;s macroglobulinemia with anti-GPIb\/IX monoclonal IgM antibody.<\/p>\n<p>Ann Hematol. 2014 Apr;93(4):711-2.<\/p>\n<hr \/>\n<p><a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Protein+kinase+C+inhibitor+generates+stable+human+tolerogenic+dendritic+cells.\">Matsumoto,T., Hasegawa,H., Onishi,S., Ishizaki,J., Suemori,K., Yasukawa,M.<\/a><\/p>\n<p>Protein kinase C inhibitor generates stable human tolerogenic dendritic cells.<\/p>\n<p>J Immunol. 2013 Sep 1;191(5):2247-57. doi: 10.4049\/jimmunol.1203053. Epub 2013 Jul 22.<\/p>\n<hr \/>\n<p><a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Clinical+characteristics+and+outcomes+of+ch%C3%A9diak-Higashi+syndrome%3A+a+nationwide+survey+of+Japan.\">Nagai,K., Ochi,F., Terui,K., Maeda,M., Ohga,S., Kanegane,H., Kitoh,T., Kogawa,K., Suzuki,N., Ohta,S., Ishida,Y., Okamura,T., Wakiguchi,H., Yasukawa,M., Ishii,E.<\/a><\/p>\n<p>Clinical characteristics and outcomes of ch\u00e9diak-Higashi syndrome: a nationwide survey of Japan.<\/p>\n<p>Pediatr Blood Cancer. 2013 Oct;60(10):1582-6. doi: 10.1002\/pbc.24637. Epub 2013 Jun 27.<\/p>\n<hr \/>\n<p><a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Development+of+a+novel+redirected+T-cell-based+adoptive+immunotherapy+targeting+human+telomerase+reverse+transcriptase+for+adult+T-cell+leukemia.\">Miyazaki,Y., Fujiwara,H., Asai,H., Ochi,F., Ochi,T., Azuma,T., Ishida,T., Okamoto,S., Mineno,J., Kuzushima,K., Shiku,H., Yasukawa,M.<\/a><\/p>\n<p>Development of a novel redirected T-cell-based adoptive immunotherapy targeting human telomerase reverse transcriptase for adult T-cell leukemia.<\/p>\n<p>Blood. 2013 Jun 13;121(24):4894-901. doi: 10.1182\/blood-2012-11-465971. Epub 2013 May 2.<\/p>\n<hr \/>\n<p><a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Adoptive+transfer+of+genetically+modified+Wilms%27+tumor+1-specific+T+cells+in+a+novel+malignant+skull+base+meningioma+model.\">Iwami, K., Natsume, A., Ohno, M., Ikeda, H., Mineno, J., Nukaya, I., Okamoto, S., Fujiwara, H., Yasukawa, M., Shiku, H., Wakabayashi, T.<\/a><\/p>\n<p>Adoptive transfer of genetically modified Wilms&rsquo; tumor 1-specific T cells in a novel malignant skull base meningioma model.<\/p>\n<p>Neuro Oncol. 2013 Jun;15(6):747-58.<\/p>\n<hr \/>\n<p><a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Co-introduced+functional+CCR2+potentiates+in+vivo+anti-lung+cancer+functionality+mediated+by+T+cells+double+gene-modified+to+express+WT1-specific+T-cell+receptor.\">Asai, H., Fujiwara, H., An, J., Ochi, T., Miyazaki, Y., Nagai, K., Okamoto, S., Mineno, J., Kuzushima, K., Shiku, H., Inoue, H., Yasukawa, M.<\/a><\/p>\n<p>Co-introduced functional CCR2 potentiates in vivo anti-lung cancer functionality mediated by T cells double gene-modified to express WT1-specific T-cell receptor.<\/p>\n<p>PLoS One 8:e56820, 2013.<\/p>\n<hr \/>\n<p><a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Novel+causative+and+neutral+mutations+in+a+patient+with+protein+C+deficiency.\">Yamanouch,i J., Hato, T., Niiya, T., Hayashi, T., Yasukawa, M.<\/a><\/p>\n<p>Novel causative and neutral mutations in a patient with protein C deficiency.<\/p>\n<p>Thromb Res. 2013 May;131(5):466-8.<\/p>\n<hr \/>\n<p><a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Analysis+of+chemotherapy-induced+neutropenia+and+optimal+timing+for+prophylactic+use+of+G-CSF+in+B-cell+non-Hodgkin+lymphoma+patients+treated+with+R-CHOP.\">Shikata, H., Yakushijin, Y., Yamanouchi, J., Azuma, T., Yasukawa, M.<\/a><\/p>\n<p>Analysis of chemotherapy-induced neutropenia and optimal timing for prophylactic use of G-CSF in B-cell non-Hodgkin lymphoma patients treated with R-CHOP.<\/p>\n<p>Int J Clin Oncol. 2014 Feb;19(1):178-85.<\/p>\n<hr \/>\n<p><a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Maximum+standard+uptake+value+of+18F-fluorodeoxyglucose+positron+emission+tomography+is+a+prognostic+factor+for+progression-free+survival+of+newly+diagnosed+patients+with+diffuse+large+B+cell+lymphoma.\">Miyazaki, Y., Nawa, Y., Miyagawa, M., Kohashi, S., Nakase, K., Yasukawa, M., Hara, M.<\/a><\/p>\n<p>Maximum standard uptake value of 18F-fluorodeoxyglucose positron emission tomography is a prognostic factor for progression-free survival of newly diagnosed patients with diffuse large B cell lymphoma.<\/p>\n<p>Ann Hematol. 92:239-244, 2013.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>\u82f1\u6587\u539f\u8457\u8ad6\u6587\u3000Original papers \u767a\u520a\u6e08\u306e\u3082\u306e\u306fabstract\u307e\u305f\u306f\u672c\u6587\u306b\u30ea\u30f3\u30af\u3057\u3066\u3042\u308a\u307e\u3059\u3002 Published papers are linked to PubMed<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[8],"tags":[17],"class_list":["post-287","post","type-post","status-publish","format-standard","hentry","category-8","tag-notice"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/int.med1\/index.php?rest_route=\/wp\/v2\/posts\/287","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/int.med1\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/int.med1\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/int.med1\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/int.med1\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=287"}],"version-history":[{"count":0,"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/int.med1\/index.php?rest_route=\/wp\/v2\/posts\/287\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/int.med1\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=287"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/int.med1\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=287"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/int.med1\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=287"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}